BeiGene
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeiGene and other ETFs, options, and stocks.About BGNE
BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products.
CEOJohn V. Oyler
CEOJohn V. Oyler
Employees10,000
Employees10,000
HeadquartersGeorge Town, George Town
HeadquartersGeorge Town, George Town
Founded2010
Founded2010
Employees10,000
Employees10,000
BGNE Key Statistics
Market cap18.52B
Market cap18.52B
Price-Earnings ratio-22.60
Price-Earnings ratio-22.60
Dividend yield—
Dividend yield—
Average volume175.43K
Average volume175.43K
High today$172.30
High today$172.30
Low today$167.56
Low today$167.56
Open price$168.23
Open price$168.23
Volume255.53K
Volume255.53K
52 Week high$245.74
52 Week high$245.74
52 Week low$126.97
52 Week low$126.97
BGNE News
Yahoo Finance 6d
The BeiGene, Ltd. First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo FinanceA week ago, BeiGene, Ltd. (NASDAQ:BGNE) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. The results overa...
Simply Wall St 7d
BeiGene First Quarter 2024 Earnings: Beats Expectations - Simply Wall StBeiGene ( ) First Quarter 2024 Results Key Financial Results Revenue: US$751.7m (up 68% from 1Q 2023). Net loss: US$251.2m (loss narrowed by 28% from 1Q 2023...
Analyst ratings
93%
of 27 ratingsBuy
92.6%
Hold
7.4%
Sell
0%